SciHub
文献互助
期刊查询
一搜即达
科研导航
即时热点
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
🔥 科研通第二届『
应助活动周
』正在进行中,3月24-30日求助秒级响应🚀,千元现金等你拿。
当前排名🏆
📚 中科院2025期刊分区📊 已更新
橙皮苷
Lv3
203 积分
2023-10-24 加入
最近求助
最近应助
互助留言
Pembrolizumab with or without bevacizumab in platinum-resistant recurrent or metastatic nasopharyngeal carcinoma: a randomised, open-label, phase 2 trial
2天前
已完结
Abstract 2882: Selective activation of CD8+ T cells by a CD8-targeted IL-21 results in enhanced anti-tumor efficacy and safety
3天前
求助中
Adjuvant systemic treatment for high-risk resected non-cutaneous melanomas: What is the evidence?
3天前
已完结
[Hodgkin lymphoma]
1个月前
已关闭
Pembrolizumab Added to Ifosfamide, Carboplatin, and Etoposide Chemotherapy for Relapsed or Refractory Classic Hodgkin Lymphoma
1个月前
已完结
Safety and Activity of Brentuximab Vedotin (BV) Plus Ifosfamide, Carboplatin, and Etoposide (ICE) for Relapsed/Refractory (Rel/Ref) Classical Hodgkin Lymphoma (cHL): Initial Results of a Phase I/II Trial
1个月前
已完结
Safety and Activity of Brentuximab Vedotin (BV) Plus Ifosfamide, Carboplatin, and Etoposide (ICE) for Relapsed/Refractory (Rel/Ref) Classical Hodgkin Lymphoma (cHL): Initial Results of a Phase I/II Trial
1个月前
已关闭
Safety and Activity of Brentuximab Vedotin (BV) Plus Ifosfamide, Carboplatin, and Etoposide (ICE) for Relapsed/Refractory (Rel/Ref) Classical Hodgkin Lymphoma (cHL): Initial Results of a Phase I/II Trial
1个月前
已关闭
[Analysis of global liver cancer statistics]
2个月前
已完结
晚期肝细胞癌免疫靶向联合转化序贯外科治疗专家共识(2024版)
2个月前
已完结
Maternal Dietary Patterns during Pregnancy and Child Autism-Related Traits: Results from Two US Cohorts
1年前
已采纳
High-content drug screening in zebrafish xenografts reveals high efficacy of dual MCL-1/BCL-XL inhibition against Ewing sarcoma
1年前
已采纳
Landscape of immunocytes infiltration and prognostic immune-related genes in hepatocellular carcinoma
1年前
已采纳
Tumour purity as an underlying key factor in tumour mutation detection in colorectal cancer
1年前
已采纳
Advances in Endoscopic Management of Endobronchial Carcinoid
1年前
已采纳
Enhancing extraction of proanthocyanidins from Chinese quince fruit by ball-milling and enzyme hydrolysis: yield, structure, and bioactivities
1年前
已采纳
Long-Term Efficacy and Safety of Anlotinib as a Monotherapy and Combined Therapy for Advanced Sarcoma
1年前
已采纳
High‐content screening of drug combinations of an mPGES‐1 inhibitor in multicellular tumor spheroids leads to mechanistic insights into neuroblastoma chemoresistance
1年前
已采纳
Effects of free weight and body mass‐based resistance training on thigh muscle size, strength and intramuscular fat in healthy young and middle‐aged individuals
1年前
已采纳
The schemes, mechanisms and molecular pathway changes of Tumor Treating Fields (TTFields) alone or in combination with radiotherapy and chemotherapy
1年前
已采纳
不需要了【积分已退回】
1个月前
无人应助【积分已退回】
8个月前
不需要了【积分已退回】
9个月前
需要正文及附录,谢谢
1年前
信息有误【积分已退回】
1年前
作者是高妍的那一篇
1年前
作者是高妍
1年前
不是这一篇,作者应该是高妍
1年前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论